About OYAGEN, INC.
OyaGen is a preclinical drug discovery and development company focused on identifying novel therapeutic indications for infectious diseases and cancer. The company's business model involves IND-enabling lead compounds for licensing or partnering with industrial leaders for clinical development.
Drug discovery from assay development to screening and mechanistic studiesFee-for-service to academia and industry partnersMethod development and testingExpert consulting services in assay development, biochemistry, structural biology, cell biology, and virologyHigh throughput drug discovery and drug development support
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to OYAGEN, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.